Rothschild & Co Redburn Issues Pessimistic Forecast for Clorox (NYSE:CLX) Stock Price

Clorox (NYSE:CLX) had its price target lowered by equities researchers at Rothschild & Co Redburn from $120.00 to $115.00 in a report released on Wednesday,MarketScreener reports. The firm presently has a “neutral” rating on the stock. Rothschild & Co Redburn’s price objective suggests a potential upside of 7.11% from the stock’s current price.

Other research analysts also recently issued reports about the stock. BNP Paribas Exane reduced their price objective on shares of Clorox from $118.00 to $110.00 and set an “underperform” rating on the stock in a research report on Friday, October 17th. Barclays decreased their price target on shares of Clorox from $118.00 to $112.00 and set an “underweight” rating for the company in a research note on Tuesday, September 30th. Bank of America cut their price objective on Clorox from $135.00 to $125.00 and set a “neutral” rating on the stock in a research report on Wednesday, October 8th. Zacks Research cut Clorox from a “hold” rating to a “strong sell” rating in a research note on Tuesday, October 28th. Finally, UBS Group set a $119.00 price target on Clorox and gave the stock a “neutral” rating in a research note on Tuesday. One research analyst has rated the stock with a Buy rating, twelve have given a Hold rating and five have assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Reduce” and an average target price of $125.69.

Clorox Price Performance

Clorox stock traded up $1.09 during midday trading on Wednesday, hitting $107.37. 1,843,132 shares of the company’s stock were exchanged, compared to its average volume of 1,706,862. The company has a market cap of $13.07 billion, a P/E ratio of 16.47, a PEG ratio of 0.92 and a beta of 0.52. The company has a debt-to-equity ratio of 5.15, a quick ratio of 0.57 and a current ratio of 0.84. The stock has a 50-day moving average price of $119.49 and a two-hundred day moving average price of $124.94. Clorox has a 52-week low of $106.14 and a 52-week high of $171.37.

Clorox (NYSE:CLX) last announced its quarterly earnings data on Monday, November 3rd. The company reported $0.85 earnings per share for the quarter, topping analysts’ consensus estimates of $0.78 by $0.07. Clorox had a net margin of 11.40% and a return on equity of 377.86%. The firm had revenue of $1.43 billion during the quarter, compared to analyst estimates of $1.41 billion. During the same period in the previous year, the business posted $1.86 EPS. The business’s quarterly revenue was down 18.9% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.950-6.300 EPS. On average, equities research analysts forecast that Clorox will post 7.15 earnings per share for the current year.

Insider Buying and Selling

In related news, COO Eric H. Reynolds sold 15,041 shares of the business’s stock in a transaction that occurred on Thursday, September 4th. The shares were sold at an average price of $123.78, for a total value of $1,861,774.98. Following the completion of the transaction, the chief operating officer owned 54,221 shares in the company, valued at $6,711,475.38. The trade was a 21.72% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. 0.63% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in CLX. Simplicity Wealth LLC lifted its holdings in Clorox by 157.3% during the second quarter. Simplicity Wealth LLC now owns 18,316 shares of the company’s stock worth $2,199,000 after acquiring an additional 11,198 shares during the period. Raymond James Financial Inc. increased its holdings in Clorox by 15.6% during the first quarter. Raymond James Financial Inc. now owns 269,926 shares of the company’s stock worth $39,747,000 after buying an additional 36,352 shares during the last quarter. OneDigital Investment Advisors LLC bought a new stake in Clorox in the first quarter worth about $247,000. AlphaQuest LLC grew its position in shares of Clorox by 109.4% during the 1st quarter. AlphaQuest LLC now owns 11,873 shares of the company’s stock valued at $1,748,000 after acquiring an additional 6,203 shares during the period. Finally, Nordea Investment Management AB increased its stake in shares of Clorox by 16.3% during the 2nd quarter. Nordea Investment Management AB now owns 484,352 shares of the company’s stock worth $57,827,000 after purchasing an additional 68,026 shares during the last quarter. Institutional investors own 78.53% of the company’s stock.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.